Compare EIKN & SORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIKN | SORN |
|---|---|---|
| Founded | 2019 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.9M | 348.0M |
| IPO Year | 2026 | 2025 |
| Metric | EIKN | SORN |
|---|---|---|
| Price | $5.67 | $10.06 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 528.2K | 85.7K |
| Earning Date | 11-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.01 | $9.81 |
| 52 Week High | $16.50 | $10.88 |
| Indicator | EIKN | SORN |
|---|---|---|
| Relative Strength Index (RSI) | 33.87 | 64.64 |
| Support Level | N/A | $9.86 |
| Resistance Level | $8.48 | $10.10 |
| Average True Range (ATR) | 0.69 | 0.01 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 19.34 | 100.00 |
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Soren Acquisition Corp is a blank check company.